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Obesity is a global epidemic, and maternal smoking has been shown to be associated with
the development of childhood obesity. Overall, approximately 40% of children worldwide
are exposed to tobacco smoke at home. It is well known that environmental changes within
a critical window of development, such as gestation or lactation, can initiate permanent
alterations in metabolism that lead to diseases in adulthood, a phenomenon called pro-
gramming. It is known that programming is based on epigenetic alterations (changes in
DNA methylation, histone acetylation, or small interfering RNA expression) that change the
expression pattern of several genes. However, little is known concerning the mechanisms
by which smoke exposure in neonatal life programs the adipose tissue and endocrine func-
tion. Here, we review several epidemiological and experimental studies that confirm the
association between maternal nicotine or tobacco exposure during gestation or lactation
and the development of obesity and endocrine dysfunction. For example, a positive correla-
tion was demonstrated in rodents between increased serum leptin in the neonatal period
and exposure of the mothers to nicotine during lactation, and the further development
of leptin and insulin resistance, and thyroid and adrenal dysfunction, in adulthood in the
same offspring. Thus, a smoke-free environment during the lactation period is essential
to improving health outcomes in adulthood and reducing the risk for future diseases. An
understanding of the pathophysiological mechanisms underlying the effects of smoking
on programming can provide new insights into therapeutic strategies for obesity.
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WORLDWIDE EPIDEMICS OF OVERWEIGHT AND OBESITY
Obesity among adults, children, and adolescents has become an
urgent problem and reached significant levels in recent years. The
World Health Organization (WHO) (2011a) declared obesity a
public health problem in 1997. Approximately 65% of the world’s
population lives in countries where overweight and obesity kills
more people than malnutrition. In 2010, the latest analysis of
the IASO/IOTF (International Obesity Taskforce, 2010) estimates
that approximately one billion adults are currently overweight and
475 million are obese. Globally, the IASO/IOTF estimates that up
to 150 million school-aged children are overweight and 50 mil-
lion are obese. Nearly 43 million children under 5 years old were
overweight in 2010, particularly in urban settings (International
Obesity Taskforce, 2010).
A higher body weight is associated with an increased risk of
developing chronic diseases, including diabetes mellitus, cardio-
vascular disease, non-alcoholic fatty liver disease, dyslipidemia,
and some of the most common cancers, alongside increased
risk of disability (Walls et al., 2012). Although obesity is highly
related to genetic factors, other factors may contribute to the
high prevalence. A strong association has been shown between
changes caused by epigenetic insults that occur in utero or early
childhood (especially during the lactation period) that impact
the regulation of metabolic pathways related to adipogenesis and
complications, including diabetes, hypertension, and dyslipidemia
(Monteiro et al., 2004; Doak et al., 2005; Ozanne et al., 2011).
WORLDWIDE TOBACCO CONSUMPTION
One of the most common pollutants is exposure to cigarette
smoke. In 2011, the WHO reported on the Global Tobacco Epi-
demic, warning about the dangers of tobacco and the impact
of smoking cessation interventions (World Health Organization
(WHO), 2011b). This same study predicted that if current trends
continue, by 2030, smoking will kill one in six people, and the
number of female smokers will significantly increase. In addition,
this study showed that tobacco is a risk factor for six of the eight
leading causes of death worldwide, including cardiac ischemia,
pulmonary obstruction, and cerebrovascular diseases, and that
most of the second-hand exposures were at home (54 vs. 37%
at workplaces).
Globally, between 80,000 and 100,000 children start smok-
ing every day [World Health Organization (WHO), 2009]. Given
these data, it is impossible not to consider the effects of cigarette
smoke on children. Approximately 40% of children worldwide are
exposed to cigarette smoke at home, and 43% have at least one
parent who smokes (World Health Organization (WHO), 2009).
This early exposure to constituents of cigarette smoke makes chil-
dren susceptible to respiratory infections, ear infections, growth
retardation, and an increased frequency of hospitalizations due to
infections (Ladomenou et al., 2009; Yilmaz et al., 2009a). More-
over, these children have decreased serum antioxidant vitamins
(A, C, and E), which can contribute to an oxy-cellular redox
imbalance and, consequently, increased lipid peroxidation and
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protein and DNA damage by free radicals present in cigarette
smoke (Yilmaz et al., 2009b). Cigarette smoke exposure during
pregnancy is related to reduced birth weight, a higher prevalence
of sudden infant death syndrome, and impaired child growth,
including decreased body mass, length, and head circumference
at 3 months of age (Hegaard et al., 2006; Fenercioglu et al., 2009).
When cigarette smoke exposure occurs during lactation, changes
in milk composition, such as lower total lipid content during the
first 6 months of lactation, are observed. Maternal tobacco use
also changes cytokine concentrations in human milk; for exam-
ple, the IL-1 concentration in the colostrum is lower in mothers
who smoke compared to non-smoking mothers (Zanardo et al.,
2005).
Cigarettes contain numerous toxic compounds, the most
important of which are polycyclic aromatic hydrocarbons, nico-
tine, thiocyanate, and carbon monoxide (Passey et al., 1971). Nico-
tine, the main addictive compound of tobacco smoke, is an alkaloid
produced in the roots of the tobacco plant and has a half-life of
2 h in humans. When nicotine is inhaled, it is quickly transported
through the bloodstream across the blood brain barrier and cellu-
lar membranes (Rosemberg, 2002). Nicotine binds to nicotinic
receptors present in neuromuscular junctions, synapses of the
central nervous system and peripheral ganglion (Taylor, 1996).
In adulthood, smoking has controversial effects on body weight
and adiposity (Chiolero et al., 2008). It has been shown that smok-
ing decreases body weight, and the smoker becomes heavier after
smoke cessation (Molarius et al., 1997). However, some studies
have shown the contrary; heavy and chronic smokers had an
increased BMI (body mass index), visceral adiposity, and insulin
resistance (Ronnemaa et al., 1996; John et al., 2005). The increased
visceral adiposity may be explained by the observations that cig-
arette smoke induces corticosterone secretion (Friedman et al.,
1987), decreases testosterone in males (Meikle et al., 1988), and
increases androgen in females (Khaw et al., 1988), which are
conditions associated with higher visceral fat.
During pregnancy, nicotine crosses the placenta and affects fetal
development (DiFranza and Lew,1995). During lactation,nicotine
is transferred through the maternal milk, and the main metabolite,
cotinine, can be found in the urine of neonates (Laurberg et al.,
2004).
PROGRAMMING
Stimuli or events that occur during critical periods of life, such
as gestation and lactation, can shape future health and disease
(Barker, 2003). This phenomenon was first defined as metabolic
programming and is now known as developmental plasticity due
to its probabilistic rather than deterministic nature (Gluckman
and Hanson, 2007; Gluckman et al., 2010). Programming appears
to play an important role in the development of obesity, which
has raised concerns throughout the international scientific com-
munity and led to the creation of a society for the study of
health maintenance and origin of diseases during development
(DOHaD – Developmental Origins of Health and Disease). Obe-
sity is considered a multifactorial disease, where events, which
occur in a critical window of life can act as triggers or adjuncts,
making the subject more susceptible to developing metabolic dis-
eases (Walls et al., 2012). Among these events, maternal exposure
to different factors, such as nutrients, hormones, and environmen-
tal pollutants, plays an important role in obesity development of
the offspring (Moura and Passos, 2005; de Moura et al., 2008). In
fact, some environmental and dietary chemicals that can mimic or
interfere with the normal action of several hormones are termed
“endocrine disruptors.” Studies predict the existence of chemical
“obesogens,” molecules that inappropriately regulate lipid metab-
olism and adipogenesis to promote obesity (Grun and Blumberg,
2006; Tabb and Blumberg, 2006).
As schematized in Figure 1, different priming factors could
act through different epigenetic mechanisms. It appears that the
obesogens could activate the processes of DNA methylation and
histone acetylation or increase the levels of some small interfer-
ence RNAs (siRNA), which can suppress genes related to normal
adipogenesis, thereby affecting the developmental plasticity of
the adipose tissue depending on the cumulative nutritional sta-
tus during life (Gluckman et al., 2007; Guilloteau et al., 2009).
Epidemiological studies of adults exposed in utero to calorie
restriction during the Dutch Hunger in World War II were the
first in which DNA hypomethylation at the imprinted IGF2 region
in mononuclear cells was demonstrated (Heijmans et al., 2008).
Those undernourished babies developed into overweight adults
who had a higher cardiovascular risk, confirming the hypothe-
sis that the early life environment can cause epigenetic changes
that persist throughout life and provide a mechanistic base for
the DOHaD theory. In addition, Suter et al. (2010, 2011a) showed
that in utero, tobacco exposure epigenetically modifies placental
CYP1A1 expression through a decrease in DNA methylation, and
this gene imprinting could explain the lower birth weight of babies
of smoking mothers. More recently, the same group (Suter et al.,
2011b) showed that a high fat maternal diet in non-human pri-
mates during gestation increases histone acetylation at the liver
Npas2 gene promoter, which is related to circadian rhythms of
lipid and glucose metabolism. Studies have suggested that perina-
tal tobacco exposure, likely due to the effects of nicotine, induces
higher histone acetylation through decreases in the expression and
activity of the sirtuins, mainly sirtuin 1, leading to a change in the
oxidative stress and inflammatory profile in the offspring (Yang
et al., 2007; Volkow, 2011). More information on epigenetic issues
has been presented in several recent reviews (Waterland et al., 2008;
Hussain, 2012).
TOBACCO AND PROGRAMMING
EPIDEMIOLOGICAL AND CLINICAL DATA
Approximately 250 billion women smoke daily worldwide. Despite
the well known harmful effects, many women continue to smoke
throughout pregnancy. In the USA, 12% of women continue to
smoke during pregnancy, resulting in the birth of at least 400,000
smoke-exposed children per year [Centers for Disease Control
and Prevention (CDC), 2012; Martin et al., 2003]. Smoking has
been associated with changes in gestation time, miscarriages, and
shorter breastfeeding duration (Mello et al., 2001; Einarson and
Riordan, 2009). During pregnancy, tobacco smoking is considered
a risk factor for perinatal mortality, low birth weight, and neuro-
logical abnormalities (DiFranza and Lew, 1995). Nicotine acts as a
potent vasoconstrictor, reducing the oxygen supply to the fetus and
affecting development. During lactation, nicotine is transferred
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FIGURE 1 |TOBACCO – one of the environmental disruptors in obesity and endocrine dysfunction development of the offspring.
through the breast milk (Luck and Nau, 1987; Dahlström et al.,
2004) and can act directly on the newborn’s metabolism. In fact,
cotinine can be detected in the urine of neonates from smok-
ing mothers. Suckling from a smoking mother has been shown
to cause tachycardia in an infant, suggesting an adrenergic effect
and demonstrating that nicotine causes important changes in
breastfeeding infants (Laurberg et al., 2004).
Several reports have demonstrated an association between
maternal smoking during pregnancy and the development of obe-
sity and hypertension in childhood and adolescence (Von Kries
et al., 2002; Wideroe et al., 2003; Goldani et al., 2007). However, it
is not clear how different effects of maternal smoking can be syner-
gistic or additive in the development of obesity in the offspring of
smoking mothers. In a Chinese population, some parameters of
metabolic syndrome, such as hypertriglyceridemia, central obe-
sity, a decreased HDL-c and an increased level of fasting serum
insulin in the adult offspring, have been associated with maternal
cigarette smoke exposure (Xie et al., 2010). Metabolic changes in
children exposed to cigarette smoke are related to the risk of devel-
oping atherosclerosis and diabetes. Epidemiological studies have
shown decreased serum HDL-c in children exposed to cigarette
smoke and increased markers of cardiovascular risk, including
leptin, C-reactive protein, and IL-6, and decreased adiponectin
concentrations (Nagel et al., 2009). Smoke exposure is also asso-
ciated with the presence of autoantibodies to pancreatic islet cells,
which would be the first step in the development of type 1 diabetes
(Skrodeniene˙ et al., 2008).
Additionally, tobacco smoke affects hormonal secretion, an
effect that can program late endocrine dysfunctions. After the
consumption of a few cigarettes, increases in ADH, GH, glu-
cocorticoids, epinephrine, and leptin can be observed (Yeh and
Barbieri, 1989; Grassi et al., 1994; Walker et al., 1999; Rese-
land et al., 2005). Even when non-smokers inhale tobacco
smoke, it can act on different endocrine-metabolic parameters.
In studies in which volunteers were subjected to environmental
tobacco smoke, similar to a profile found in a bar/restaurant,
increases of resting energy expenditure and serum thyroid hor-
mones were observed with only 1 h of exposure (Metsios et al.,
2007). In a similar study, the same increase in thyroid hor-
mones was observed, along with increased production of the
pro-inflammatory cytokine IL-1β and increased systolic blood
pressure (Flouris et al., 2008). These hormonal changes should
be further investigated because children of smoker mothers
may have a higher risk of developing endocrine diseases later
in life.
EXPERIMENTAL DATA
For a better understanding of the role of tobacco smoke in the
pathophysiology of obesity, researchers have used experimental
models that allow the study of each tobacco component that may
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be involved in the development of obesity and, thus, provide a
mechanistic basis prevention and treatment.
Experimental data have confirmed the epidemiological data
associating maternal smoking during pregnancy with the develop-
ment of obesity (Gao et al., 2005; Holloway et al., 2005; Somm et al.,
2008). Williams and Kanagasabai (1984) showed that fetal nico-
tine exposure in rats increases body fat in the fetus on the 20th day
of gestation (birth on the 21st day), suggesting that fetal nicotine
exposure results in increased adiposity in the offspring. Newman
et al. (1999) observed that rats exposed to nicotine in utero are
heavier at 9 weeks of age compared with controls. In rodents,
nicotine exposure from gestation to the 10th day of lactation
increased body weight in offspring at 35 days of age. In male off-
spring, this effect was transient, but in female offspring, the higher
body weight persisted until 90 days of age (Chen and Kelly, 2005).
In addition, rats whose mothers were treated with nicotine for
14 days before mating and during pregnancy until weaning were
heavier at 70 days of age compared with controls and had higher
body weight and visceral adipose tissue at 180 days of age (Gao
et al., 2005). In addition to obesity, adult animals whose moth-
ers were exposed to nicotine during both gestation and lactation
also display insulin resistance, glucose intolerance, cold intoler-
ance, a reduction in spontaneous physical activity, and higher risk
of developing cardiovascular diseases (Bruin et al., 2007; Somm
et al., 2008, 2009).
It is interesting to note that most studies have investigated the
effects of nicotine in rodents during gestation, which is equivalent
in terms of neural development to the first two trimesters of gesta-
tion in humans. Considering neural development, lactation in rats
is thought to be equivalent to the third trimester of human gesta-
tion (Quinn, 2005; Clancy et al., 2007). For eutherian mammals,
the function of lactation is to provide the primary source of nutri-
tion and immune protection to the offspring after birth (Golding
et al., 1997). Because this period is critical to cognitive and neuro-
logical development, adverse environmental changes can predis-
pose newborns to the development of some diseases in adulthood
(Mott et al., 1991; Symonds, 2007). Nevertheless, despite experi-
mental data of smoking/nicotine programming during pregnancy
or gestation and lactation, to the best of our knowledge, there are
few studies that have evaluated the effects of nicotine or tobacco
exposure exclusively during the early postnatal period. This may
be of particular relevance because there is a high rate of smok-
ing relapse among women who quit smoking during pregnancy
(McBride and Pirie, 1990). In fact, our group suggested that the
postnatal period is critical for nicotine programming of body
weight and fat distribution. Despite the differences in the neural
development of rats and humans, studies that focus exclusively
on the lactation period are important in evaluating the possible
programming effects of neonatal exposure to cigarette smoke.
Hormonal changes associated with nicotine/tobacco exposure
during lactation
Our group has shown that maternal nicotine exposure
(6 mg/kg/day) from day 2 to 16 of lactation causes neona-
tal hyperleptinemia and primary hypothyroidism and programs
for overweight, higher visceral adiposity, adipocyte hypertrophy,
hyperleptinemia, leptin and insulin resistance, and secondary
hypothyroidism in adult rat offspring (Oliveira et al., 2009; de
Oliveira et al., 2010).
Increased body fat is associated with higher levels of leptin
(Friedman and Halaas, 1998); however, the association between
tobacco/nicotine and leptin levels is still controversial because
both hyperleptinemia (Hodge et al., 1997; Eliasson and Smith,
1999; Nicklas et al., 1999) and hypoleptinemia (Wei et al., 1997;
Donahue et al., 1999) have been found in tobacco smokers. The
significance of higher serum leptin levels and the effect on leptin
action are unclear because in most cases, it is associated with leptin
resistance. Nevertheless, leptin resistance can be tissue-specific. It
has been shown (Rahmouni et al., 2008) that in some knockout
mice models of Bardet–Biedl obesity syndrome, leptin resistance
has anorexigenic effects; however, leptin preserves its effects on
renal sympathetic nerve activity. Our group also demonstrated
that even in the sympathetic nervous system (SNS), a peripheral
adrenal medulla leptin resistance is present, while the central leptin
action upon the SNS is preserved (Trevenzoli et al., 2010).
Some leptin effects on energy balance may be mediated by
the hypothalamus-pituitary-thyroid axis and peripheral metab-
olism of thyroid hormones (Ahima et al., 1996; Légradi et al.,
1997; Friedman and Halaas, 1998; Seoane et al., 2000; Nowak
et al., 2002; Ortiga-Carvalho et al., 2002; Lisboa et al., 2003). In
fact, disturbances of thyroid function are associated with marked
changes in both energy expenditure and body weight, with lep-
tin and thyroid hormones appearing to play mutually important
roles. It is well known that tobacco can affect the thyroid gland
(Christensen et al., 1984; Ericsson and Lindgrade, 1991; Fisher
et al., 1997; Utiger, 1998), and although there are few studies con-
cerning the effect of tobacco compounds on thyroid function,
thiocyanate, not nicotine, is frequently related to hypothyroidism
and goiter (Muller et al., 1995; Dai et al., 1996; Fukata et al., 1996;
Eskandari et al., 1997). Maternal smoking influences the thyroid
function of the newborn differently, likely according to the levels
of iodine-intake. In newborns of normal iodine-intake mothers,
it appears that smoke is related to neonatal hyperthyroidism sup-
pressing TSH (Meberg and Marstein, 1986), while in borderline
iodine-intake mothers, smoke exposure is associated with goi-
ter (Chanoine et al., 1991). According to Laurberg et al. (2004),
smoking mothers have lower iodide content in breast milk, and
their offspring have lower urinary iodide. This study suggests that
nicotine decreases maternal milk iodide transfer.
As we previously described thyroid hypofunction in rat pups
after maternal exposure to nicotine, we decided to evaluate the
transfer of iodine through milk in this model (de Oliveira et al.,
2011). As schematized in Figure 2, during nicotine exposure,
mothers showed decreased serum T4 and mammary radioiodine
uptake (RAIU) and increased serum TSH and thyroid RAIU, fol-
lowed by higher T3 content in milk. In addition to decreased T3
and T4 and increased TSH levels, pups from nicotine mothers
showed lower thyroid RAIU. Interestingly, at weaning after nico-
tine withdrawal, the pups recovered thyroid function, likely due
to the increased lactational transfer of T3. Therefore, we demon-
strated that the thyroid function of both mothers and pups was
affected by early nicotine exposure. The likely mechanism of the
pups’ primary hypothyroidism is decreased leptin signaling in the
thyroid. However, long-term thyroid hypofunction is related to
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FIGURE 2 |The anti-thyroid effect of nicotine during lactation.
central and peripheral leptin resistance in adulthood (Santos-Silva
et al., 2010).
In another study (Pinheiro et al., 2011), we investigated the
association of leptin and adrenal hormones in adult male off-
spring whose mothers were treated with nicotine during lacta-
tion. These progeny presented with higher production of adrenal
catecholamine but lower catecholamine secretion. They also dis-
played hypothalamic-pituitary-adrenal axis hyperfunction, char-
acterized by an increase in both CRH and ACTH immunostaining
in the hypothalamus and pituitary and higher serum corticos-
terone levels. Because obesity depends on SNS and hypothalamic-
pituitary-adrenal function, these findings could be associated with
a higher probability of developing obesity due to lower cate-
cholamine secretion (reducing the lipolytic effects of SNS) and
higher corticosterone action (increasing visceral adipogenesis).
Thus, our studies identified lactation as a critical period for
nicotine programming for obesity, with both thyroid and adrenal
dysfunctions being possible contributing factors. In addition,
through the effects of nicotine, perinatal maternal smoking can
be responsible for the future development of some components of
the metabolic syndrome in offspring.
Table 1 presents some findings concerning a sex dimorphism in
a model of maternal nicotine exposure during lactation. Adrenal
function in adult offspring was programmed only in male off-
spring, while female offspring showed only changes in leptin
content in muscle and adipocytes (Pinheiro et al., 2011). Thus,
males may be more susceptible to maternal smoke-induced obesity
than females. It is possible that the resistance to the programming
found in female rats is an evolutionary advantage because the
environmental changes are not fully transmitted to the progeny.
However, there is lack of epidemiological studies to support this
hypothesis.
A cigarette contains more than 4,500 compounds in addition
to nicotine. Therefore, it is interesting to evaluate the effects of
total cigarette exposure during lactation. To evaluate this possible
Table 1 | Comparison between some parameters of adult (180days of
age) male and female rat progeny whose mothers were
nicotine-treated only during lactation period.
180days of age Male
offspring
Female
offspring
BIOMETRIC PARAMETERS
Visceral adipose tissue mass ↑ Unchanged
Total body fat mass ↑ ↓
Subcutaneous fat mass Unchanged ↓
Total body protein ↑ ↓
SERUM HORMONES
Leptin ↑ Unchanged
Corticosterone ↑ Unchanged
ADRENAL PARAMETERS
Gland mass Unchanged Unchanged
Catecholamine content ↑ Unchanged
Tyrosine hydroxylase ↑ Unchanged
TISSUE PROTEIN CONTENT
Leptin in visceral adipocyte ↑ Unchanged
Leptin in subcutaneous adipocyte Unchanged ↓
Leptin in soleus muscle Unchanged ↓
Adrenergic β3 receptor in visceral adipocyte ↑ ↓
combined programming effect of cigarette compounds, we more
recently developed a model of maternal cigarette smoking expo-
sure during lactation to investigate some nutritional, biochemical,
and hormonal parameters in dams and pups. In this experiment,
lactating rats were submitted to a smoking machine 4 times/day/h
for each exposure (1.7 mg nicotine/cigarette) during the lacta-
tion period without pups to attempt to reproduce the human
conditions in which the lactating mother only smokes far from
her baby. Different from the pups whose mothers were exposed
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solely to nicotine, the pups from smoke-exposed mothers did not
exhibit neonatal thyroid dysfunction and had lower body adipos-
ity. In addition, they had lower adrenal catecholamine content and
lower serum corticosterone levels at weaning (Santos-Silva et al.,
2011). The only programming effect noted in the offspring was
decreased catecholamine production in the adrenal gland at adult-
hood, a dysfunction that can lead to long-lasting changes in the
stress response. However, these adult offspring surprisingly had no
changes in body adiposity or serum hormone profile (Santos-Silva
et al., 2012). Other cigarette components may inhibit the obeso-
genic effect of nicotine, or more likely, the time period of exposure
(4 h/day) was not adequate to transfer enough nicotine to the pups.
Another point to consider is that the newborn may be exposed to
cigarette smoke in the environment because relatives other than
the mother, such the father, can also smoke. Thus, we are studying
another model in which the pups stay with the mother during the
full period of cigarette smoke exposure in the smoke chamber.
To clearly elucidate the effect of tobacco programming, Tables 2
and 3 depict the major changes found into two models of smoke
exposure during lactation in rodents, namely, maternal nico-
tine exposure (Oliveira et al., 2010) and cigarette smoke expo-
sure (Santos-Silva et al., 2011). Our comparison of these two
experimental models suggest that some changes result specifically
from nicotine exposure, such as thyroid and adrenal dysfunction,
serum HDL-c and leptinemia. Surprisingly, some of the nicotine
effects were blunted when the animals were exposed to the cig-
arette smoke, such as thyroid dysfunction and hyperleptinemia.
In addition, components of tobacco other than nicotine may be
responsible for the alterations in triglycerides and LDL-c.
Our experimental data and data from the literature (experi-
mental, clinical, and epidemiological) show that maternal smok-
ing, mainly through nicotine/tobacco smoke exposure in early life,
can significantly influence neonate development, with an emphasis
on obesity.
CONCLUDING REMARKS – PERSPECTIVES
Smoking during pregnancy and lactation remains a major scien-
tific and public health concern and are associated with numerous
short- and long-term adverse effects. We can learn from the devel-
opmental programming induced by maternal smoking, and its
future impact on endocrine dysfunction and obesity that in addi-
tion to its clear toxic effects, tobacco smoke has long-term effects
contributing to the obesity epidemic.
We do not yet know all of the mechanisms by which this early
life exposure leads to the observed changes in adipogenesis or
hormonal changes, including epigenetic alterations. Unanswered
questions remain concerning the role of hormonal or transcript
factors, such as PPARgamma, on the adipogenesis in this condition
and how the different factors that are changed during the neona-
tal period combine to increase the probability of these reported
developmental changes.
The possibility that tobacco compounds can make children who
are exposed to cigarette smoke during the gestation and/or lac-
tation periods, through blood cord, milk, or environment, more
susceptible to obesity and other metabolic and endocrine disorders
in adulthood warrants clinical, epidemiological, prospective, and
experimental studies that support a more assertive health policy by
Table 2 | Comparison between milk composition in the models of
maternal nicotine and tobacco smoke-exposed during lactation.
Nicotine Tobacco
Cotinine ↑ ↑
Calories ↑ ↑
Lactose ↑ ↑
Protein Unchanged Unchanged
Cholesterol Unchanged Unchanged
Triglycerides Unchanged ↑
Table 3 | Comparison between metabolic and endocrine changes in
the models of maternal nicotine and tobacco smoke-exposed during
lactation.
Mother Male pups
Serum cotinine Tobacco ↑ ↑
Nicotine ↑ ↑
Serum cholesterol Tobacco Unchanged Unchanged
Nicotine Unchanged Unchanged
Serum HDL-c Tobacco ↑ ↑
Nicotine ↑ ↑
Serum LDL-c Tobacco Unchanged ↓
Nicotine Unchanged Unchanged
Serum VLDL-c Tobacco ↑ Unchanged
Nicotine Unchanged Unchanged
Serum triglycerides Tobacco ↑ ↑
Nicotine Unchanged Unchanged
Serum leptin Tobacco Unchanged Unchanged
Nicotine ↑ ↑
Serum triiodothyronine Tobacco Unchanged Unchanged
Nicotine Unchanged ↑
Serum thyroxine Tobacco Unchanged Unchanged
Nicotine ↓ ↓
Serum corticosterone Tobacco Unchanged ↑
Nicotine Unchanged ↑
Adrenal catecholamine content Tobacco Unchanged ↑
Nicotine Unchanged ↑
governments toward education about the risk of cigarette smoke,
at least in vulnerable periods of life, such gestation, lactation, and
infancy.
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